Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market Expected to Reach $7.05 Billion by 2027
Request for Free Sample Report at: https://www.alliedmarketresearch.com/request-sample/3810
The key factors such as rise in demand for DTaP vaccine and growth in adoption of pertussis vaccine around the globe drives the growth of DTaP segment. Furthermore, high efficacy and rise in demand in developing regions is expected to drive the market during the forecast period. In addition, introduction of new combination of vaccines with DTaP further provides opportunities for the market players.
On the basis of age group segment, the pediatric segment is expected to grow at a significant CAGR of 4.9% during the forecast period, owing to increase in obese population worldwide. Vaccines for adults are likely to show high growth potential due to rise in incidences of infectious diseases among adults. In addition, growth in research and development and strong product pipeline is also likely to increase growth of the segment during the forecast period.
By end user, in 2019, the hospitals segment dominated the DTP vaccines market, with large share due to faster availability of these vaccines in hospitals and shorter duration of procedure. Hospitals are the integral part of the healthcare sector, which act as the major source for revenue generation and aid in research and innovation.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/3810
Key Findings Of The Study
• DTaP is expected to be one of the most lucrative segments, registering a CAGR of 5.0% during the forecast period.
• The Pediatric segment accounted for maximum share in the global DTP vaccines market in 2019, and is expected to grow at a CAGR of 4.9% during the forecast period.
• U.S. dominated the North America DTP Vaccine market, and is projected to retain this trend throughout the forecast period.
• India is expected to exhibit the highest growth in the Asia-Pacific DTP Vaccine market, registering a CAGR of 6.6% during the forecast period.
• South Africa is expected to witness the highest growth in the LAMEA DTP Vaccine market, growing at a CAGR of 5.5% during the forecast period.
In 2019, North America is expected to remain dominant during the forecast period due to high awareness and demand for DTaP vaccines and presence of major key players along with R&D laboratories. In addition, wide availability of advanced systems supplements the growth of the DTP vaccines market. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to the increasing awareness in countries such as India and China.
Get detailed (COVID-19 impact) analysis: https://www.alliedmarketresearch.com/diphtheria-pertussis-and-tetanus-vaccine-market
The key players operating in the global DTaP vaccine market are AJ Vaccines, Bionet-Asia, GlaxoSmithKline plc (GSK), Johnson & Johnson, Massbiologics, Meiji Holdings Co., Ltd. (KM biologics co., Ltd.), Merck & Co., Inc., Panacea Biotec Ltd., Sanofi, and Serum Institute of India Pvt. Ltd
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market Expected to Reach $7.05 Billion by 2027 here
News-ID: 2172078 • Views: 140
More Releases from Allied Market Research
Ultrasonic Air Bubble Detectors Market Size & Share | Analysis - 2026
UPCOMING REPORT’S INTRODUCTION: According to an upcoming report of Allied Market Research, titled, “Ultrasonic Air Bubble Detectors Market”, the Ultrasonic Air Bubble Detectors market is expected to grow sustainably from 2020 to 2027. The report offers a comprehensive analysis of various growth drivers of the Ultrasonic Air Bubble Detectors market. The analysis ranges from revenue and operations to future growth opportunities. This comprehensive analysis of great importance for stakeholders to
World GPS Tracking Device Market - Opportunities and Forecasts, 2020-2027
Analyzing the current situation of pandemic, Allied market research has published a report t, which says, the GPS Tracking Device market is expected to grow at a faster pace by 2027. The researchers have intelligently made analysis and forecasts of the future growth by taking the past performance and data into consideration. The analysis offered by the report will surely provide valuable insights to the stakeholders of the GPS Tracking
Automotive Smart Helmet Market Statistics 2020: Advanced Technologies, Trends, C …
Allied Market Research published a new report, titled, "Automotive Smart Helmet Market." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Get detailed COVID-19 impact
Hybrid Funds Market Size, Share and Growth | Analysis - 2027
INTRODUCTION TO REPORT The report published by Allied market research, titled, “Hybrid Funds Market”, offers a comprehensive analysis of key growth drivers, key segments, development strategies, market opportunities, and competitive landscape. This study offers detailed insights for market players, investors, stakeholders, and new entrants to understand the industry dynamics and determine strategic steps to gain the competitive advantage. COVID_19 Scenarios: The Hybrid Funds has been the worst hit by COVID-19 globally. Based
More Releases for DTP
Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market Expected to Reach $7.05 …
The global DTP vaccines market is expected to grow at a steady rate during the forecast period, owing to growth in awareness among people about the advantages of DTP vaccines globally, especially in developing countries. Moreover, rise in initiatives by pharma companies to enhance vaccine R&D is anticipated to supplement the DTP vaccines market growth. In addition, collaboration among the vaccine market stakeholders to employ combination of all available product
Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market Expected to Reach $7.05 …
According to a new report published by Allied Market Research, titled, “Diphtheria, Tetanus, and Pertussis (DTP) Vaccine Market by Product, Age Group, and End User: Opportunity Analysis and Industry Forecast, 2020–2027," the global Diphtheria, Tetanus, and Pertussis Vaccine market was valued at $ 4,758.8 million in 2019 and is expected to reach $ 7,054.4 million by 2027, with a CAGR of 5.1% from 2020-2027. The DTaP segment accounted for major
Positive Impact Of COVID 19 On Diphtheria, Tetanus and Pertussis (DTP) Vaccine M …
According to a new report entitled “Diphtheria, Tetanus and Pertussis (DTP) Vaccine Market by Product, Age Group and End User: Opportunity Analysis and Industry Forecast from 2020 to 2027” by Allied Market Research, the tetanus and whooping cough vaccine market is It is expected to reach $7,0544 million by 2027 with an average annual growth rate of 5.1% in 2020-2027 at $4,758.8 million in 2019. The DTaP segment occupied a
DTP works as part of the »virtual evolution« are still incomprehensible
»In your best interest, we at dtp-works.de cannot and do not want to make any mistakes. « © Cited from: dtp-works.de (four-eye principle) http://dtp-works.com/about_us/ These seem like brave words. But the company, literally born on the emergence of the virtual world, knows the reason for this statement. Target markets are flooded by offers “from every corner of the world”. The public is privileged enough to choose. He who makes the least mistakes –
The »brave new world« of dtp work in the best of hands at dtp-works_de
»Web globalisation and web localisation include layout checking in market-related target languages in your sector. « © Quotation: dtp-works_de (services - http://dtp-works.de/leistungen/dienste/) The modern-day world of advertising has been graced with a range of catalogues, brochures, and page upon page of business reports, and translators would spend months on their conversion into other languages. Then it was the turn of the layout and printing people to prepare each magnum opus for the
Web-based DTP-Workflow with Contentserv’s InCopy Connector
Rohrbach/Ilm, Germany, July 07, 2011: Adobe’s® InCopy® Workflow, loved by so many distributed editorial teams, is now incorporated into Contentserv’s publishing process via Contentserv’s new InCopy Connector. This combines the benefits of Adobe’s excellent plugin with the advantages of centralized, web-based collaboration, without requiring a local installation of InDesign®. Beginning with Contentserv’s latest version, CS11.2, the new InCopy Connector will be available to all Contentserv users using the InDesign® Webeditor. With